−157.55 M TWD
39.91 M TWD
About Enimmune corporation
Sector
Industry
CEO
Che Wei Chang
Website
Headquarters
Taipei
Founded
2014
ISIN
TW0006564008
FIGI
BBG00M0C0FW5
Enimmune Corp. engages in the research, development of new drugs. Its products include EV71, Japanese encephalitis virus, EV71+CA16 bivalent, tetanus toxoid adsorbed, influenza, AH1N1, and pneumococcal vaccines. The company operates pharmaceutical outlets. Enimmune was founded on January 10, 2014 and is headquartered in Taipei, Taiwan.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6564 is 20.55 TWD — it has decreased by −0.72% in the past 24 hours. Watch Enimmune corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange Enimmune corporation stocks are traded under the ticker 6564.
6564 stock has risen by 1.23% compared to the previous week, the month change is a 22.32% rise, over the last year Enimmune corporation has showed a −40.35% decrease.
6564 reached its all-time high on Jul 6, 2020 with the price of 124.85 TWD, and its all-time low was 14.00 TWD and was reached on Mar 19, 2020. View more price dynamics on 6564 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6564 stock is 3.76% volatile and has beta coefficient of 0.86. Track Enimmune corporation stock price on the chart and check out the list of the most volatile stocks — is Enimmune corporation there?
Today Enimmune corporation has the market capitalization of 1.49 B, it has increased by 1.97% over the last week.
Yes, you can track Enimmune corporation financials in yearly and quarterly reports right on TradingView.
6564 net income for the last half-year is −92.49 M TWD, while the previous report showed −146.03 M TWD of net income which accounts for 36.66% change. Track more Enimmune corporation financial stats to get the full picture.
No, 6564 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6564 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enimmune corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enimmune corporation technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enimmune corporation stock shows the sell signal. See more of Enimmune corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.